Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析

◆英語タイトル:Coherus BioSciences Inc (CHRS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH410367FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used for the treatment of ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis, psoriasis arthritis and rheumatoid arthritis; and CHS-1420, is a adalimumab biosimilar candidate, which is being developed to treat crohn’s disease, ulcerative colitis, and psoriasis arthritis, UDENYCA is a pegfilgrastim biosimilar, CHS-3351 a ranibizumab biosimilar, CHS-2020 a aflibercept biosimilar and CHS-131 a Selective PPAR-gamma modulator. Coherus capabilities includes process science, analytical characterization, protein production and clinical-regulatory development. The company develops drugs in collaboration with other organizations. Coherus is headquartered in Redwood City, California, the US.

Coherus BioSciences Inc Key Recent Developments

Feb 25,2021: Coherus Management to Present at Upcoming Investor Conferences
Feb 24,2021: Coherus BioSciences reports fourth quarter and full year 2020 financial results
Feb 18,2021: Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
Feb 16,2021: Coherus Announces CFO Transition Plans
Feb 12,2021: Coherus BioSciences: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

This comprehensive SWOT profile of Coherus BioSciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Coherus BioSciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Coherus BioSciences Inc – Key Information
Coherus BioSciences Inc – Overview
Coherus BioSciences Inc – Key Employees
Coherus BioSciences Inc – Key Employee Biographies
Coherus BioSciences Inc – Key Operational Heads
Coherus BioSciences Inc – Major Products and Services
Coherus BioSciences Inc – History
Coherus BioSciences Inc – Company Statement
Coherus BioSciences Inc – Locations And Subsidiaries
Coherus BioSciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Coherus BioSciences Inc – Business Description
Coherus BioSciences Inc – Corporate Strategy
Coherus BioSciences Inc – SWOT Analysis
SWOT Analysis – Overview
Coherus BioSciences Inc – Strengths
Coherus BioSciences Inc – Weaknesses
Coherus BioSciences Inc – Opportunities
Coherus BioSciences Inc – Threats
Coherus BioSciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Coherus BioSciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Coherus BioSciences Inc, Key Information
Coherus BioSciences Inc, Key Ratios
Coherus BioSciences Inc, Share Data
Coherus BioSciences Inc, Major Products and Services
Coherus BioSciences Inc, History
Coherus BioSciences Inc, Key Employees
Coherus BioSciences Inc, Key Employee Biographies
Coherus BioSciences Inc, Key Operational Heads
Coherus BioSciences Inc, Other Locations
Coherus BioSciences Inc, Subsidiaries
Coherus BioSciences Inc, Key Competitors
Coherus BioSciences Inc, SWOT Analysis
Coherus BioSciences Inc, Ratios based on current share price
Coherus BioSciences Inc, Annual Ratios
Coherus BioSciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Caltex Australia Ltd (CTX)-石油・ガス分野:企業M&A・提携分析
    Summary Caltex Australia Limited (Caltex) is a transport fuel supplier and convenience retailer. It is the parent company of Caltex group. The company purchases, refines, distributes and markets petroleum products. It owns and operates refinery, convenience stores, road tankers, storage terminals, s …
  • Essilor International Compagnie Generale d’Optique SA (EI):医療機器:M&Aディール及び事業提携情報
    Summary Essilor International Compagnie Generale d'Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatis …
  • Shelby Energy Cooperative, Inc.:企業の発電所・SWOT分析2018
    Shelby Energy Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • Endo International plc:企業の戦略・SWOT・財務情報
    Endo International plc - Strategy, SWOT and Corporate Finance Report Summary Endo International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zhejiang Yatai Pharmaceutical Co Ltd (002370):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Yatai Pharmaceutical Co Ltd (Yatai Pharmaceutical), formerly Asia-Pacific Pharmaceutical Factory, is a pharmaceutical company. The company develops, researches, and manufactures pharmaceuticals including penicillin, cephalosporins and hormones. It offers transdermal controlled-relea …
  • Abg Sundal Collier Holding Asa
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Toshiba Corporation:企業の戦略・SWOT・財務分析
    Toshiba Corporation - Strategy, SWOT and Corporate Finance Report Summary Toshiba Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Terumo Corp (4543):製薬・医療:M&Aディール及び事業提携情報
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • Royal Energy Resources Inc (ROYE):石油・ガス:M&Aディール及び事業提携情報
    Summary Royal Energy Resources Inc (Royal Energy), formerly World Marketing Inc is an oil and gas company that invest on energy industry and its properties. The company acquires, operates and develops coal, natural gas, and renewable fuels energy assets. It offers services such as energy recovery an …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Motus Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motus Therapeutics Inc (Motus), formerly Rhythm Pharmaceuticals, Inc. is a subsidiary of Rhythm Holding Company LLC, biotechnology company that provides therapies. The company develops peptide therapeutics for the treatment of metabolic diseases. Its products under clinical development inclu …
  • Jamaica Public Service Co Ltd:発電所・企業SWOT分析
    Jamaica Public Service Co Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nuverra Environmental Solutions, Inc. (NES)-石油・ガス分野:企業M&A・提携分析
    Summary Nuverra Environmental Solutions, Inc. (Nuverra), formerly known as Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, coll …
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • At Home Group Inc. (HOME):企業の財務・戦略的SWOT分析
    At Home Group Inc. (HOME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Patara Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Patara Pharma Inc (Patara Pharma) is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of chronic inflammatory and fibrosis. The company develops anti-inflammatory therapeutics for lung diseases and immune disorders. It conducts clinical trials and in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆